Poor Bayer! They disclosed on Monday that they had received a subpoena from the U.S. attorney for New Jersey relating to its withdrawn Baycol (cerivastatin) anti-cholesterol drug.
Bayer received the subpoena last month, according to the company's annual report filed with the Securities and Exchange Commission.
The German pharmaceutical and chemical company had received a subpoena in January 2004 that also related to its Baycol drug from the Defense Criminal Investigative Service of the U.S. Department of Defense Inspector General.
Bayer withdrew Baycol from the market in August 2001 after it was allegedly linked to about 100 deaths.
Bayer said that as of Jan. 13 it had paid $1.15 billion to settle 3,082 Baycol cases, without acknowledging any liability.
That's $337,000 per case. And Merck have how many Vioxx cases outstanding? Oh yes, around 9,000 and counting.
Source: Dow Jones Newswires
No comments:
Post a Comment